PHILADELPHIA, November 9 – Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Charlene Sanders, M.D., F.A.A.P. to the position of Vice President, Global Regulatory Affairs and Pediatric Strategic Consulting. Dr. Sanders is able to leverage her career experiences, both in global regulatory management and medical practice, to bring a wealth of knowledge to the Premier Research team.
Dr. Sanders’ brings extensive regulatory expertise including more than 15 years of pharmaceutical management experience. Her experience in drug development and regulatory affairs includes interactions with both the regulators and major pharmaceutical companies (Merck, Duramed Research, and Sanyko Pharma Development). Dr. Sander’s therapeutic experience in oncology, neuroscience, pain and pediatrics is well aligned with the company’s therapeutic focus. She trained in pediatrics and has had post-doctoral specialty fellowships. She has held teaching faculty appointments at the Children’s Hospital of Los Angeles, Morgan Stanley Children’s Hospital (Columbia University Medical Center), Children’s Hospital of Boston (Harvard University) and Yale University. She received her Medical Degree from the University of Pennsylvania School of Medicine and as well as her undergraduate degree through Penn’s University Scholars’ Program.
“Charlene has the ideal mix of global regulatory affairs and medical expertise to assist our sponsors through the highly regulated drug development process and formulate successful strategies for interacting with the regulatory agencies,” said Krista Armstrong, PhD, Vice President, Global Clinical Trial Management. “In addition, her substantial pediatric clinical expertise further strengthens our organization as the premier provider of pediatric clinical research.”
About Premier Research
Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. With a network of skilled staff operating across North America and Europe and partnerships in Latin America, Asia, South Africa, Australia and the Middle East, Premier Research manages Phase 1-4 trials and programs.
They are leaders in clinical research for analgesia, oncology, neuroscience, and cardiovascular and have a wealth of experience in medical device and pediatric research. They offer a comprehensive selection of services for every phase of clinical development including, regulatory affairs, clinical trial management, clinical research centers, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, IVRS/IWRS, quality assurance, and functional sourcing.
www.premier-research.com
For further information, please contact:
Jessica Barag jessica.barag@premier-research.com (215) 282-5391
